Protective Effects of Oroxylin A against Doxorubicin-Induced Cardiotoxicity via the Activation of Sirt1 in Mice

Figure 2

OA treatment improved contractile function in cardiomyocytes. (a) Resting cell length (). (b) Peak shortening (). (c, d) ±dL/dt (). Differences between multiple groups were determined by one-way ANOVA followed by Tukey’s test. vs. control group, ^# vs. DOX group.

(a)

(b)

(c)

(d)